PRAC meeting highlights 13-16 March 2023

The European Medicines Agency's Pharmacovigilance Risk Assessment Committee (PRAC) is responsible for assessing and monitoring safety issues for human medicines.

The PRAC did not start or conclude any referral procedures during the March 2023 meeting. More information on all safety reviews currently under evaluation is provided in the 'Ongoing referrals' table.